Cardiovascular Systems (CSII) Gains Traction-Good Value Play
Cardiovascular Systems(CSII) is a medical device Company that focuses on interventional treatment for peripheral arterial disease(PAD). The primary products are the Diamondback 360 and the Predator 360, minimally invasive catheter systems for a range of plaque types in leg arteries.PAD...
RaynoLifeScience Portfolio: Earnings Update-ABAX,GPRO
Abaxis (ABAX) beat estimates with reported Q3 Revenues of $35.3M/$0.17 up 17% over last year's comparable quarter. Cash position is $100.6M up from $87.6M last year's Q3. March '11 Fiscal Year estimates are $143M and $0.72/sh. Shares are up 0.97% today to $24 level up from low of $22.40 on...
Trading Update:Exact Sciences (EXAS) Reports Positive Data for Colorectal Cancer Test
EXAS -Big Sell-Off on the News Exact Sciences (EXAS) was down 20% today after presenting its first validation data on the performance of its experimental, non-invasive colorectal cancer test. As of midday trading the stock was around $6.90 on huge volume over 5.5 M shares. The stock took off...
Great Day for Biotech Tools:Earnings Up ILMN,LIFE and PacBio (PACB) IPO
Timing is everything and Pacific Biosciences(PACB) took advantage of a good year for biotech stocks, better earnings for tools and Dx companies and a rebounding IPO market. Pacific Biosciences raised $200M($16) at the midpoint of the expected range and shares advanced to $16.25 with midday...
GE Buys Oncology Diagnostic Co. Clarient (CLRT)-Update- Dx Movers
GE announced the purchase of Clarient (CLRT) for $5/share or $580M, a 34% premium over Clarient's previous closing price. Revenues forecasted for 2011 and 2012 are at $114M and $136M respectively, pricing the deal at a Price to Sales of 4.25 to 5X. Revenues for Q1 were $26.6M with a loss of...